grade
pharmaceutical primary standard
API family
nadroparin
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Nadroparin calcium EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
涉药品监管产品
此项目有
G M Andreozzi et al.
Minerva cardioangiologica, 48(12 Suppl 1), 9-14 (2001-03-20)
Thrombophlebitis of the superficial veins (SVT) of the leg is usually regarded as a mild and uncomplicated disease. Although this is generally true for acute thrombosis of the branches of the saphenous vein, the natural history of SVT involving the
Gabriel Lima-Oliveira et al.
Clinical biochemistry, 45(9), 683-687 (2012-03-24)
Evaluate whether four different brands/types of heparin coated syringes can represent a source of variability in blood gas analysis (BGA). Blood was collected from one hundred volunteers into different syringes: Syringe I (lithium heparin and calcium balanced); Syringe II: in-house
Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
Maria Maroto-Iitani et al.
Contact dermatitis, 52(4), 228-230 (2005-04-30)
C E Geffroy et al.
Presse medicale (Paris, France : 1983), 31(7), 303-311 (2002-03-20)
To control whether prescriptions of curative doses of heparin (non fractioned heparins, enoxaparin, tinzaparin) in the hospital complied with the official recommendations; to provide the physicians with information adapted to the recorded misuse and to evaluate the influence of this
T Ripert et al.
Transplantation proceedings, 41(10), 4193-4196 (2009-12-17)
Renal allograft vascular thrombosis is a complication that often results in graft loss. Since there are no guidelines on immediate postoperative thromboprophylaxis, we performed a telephone survey of clinical practice in all renal transplantation centers in France. Each center considered
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持